Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 48.7 NOK -3.56% Market Closed
Market Cap: 1.3B NOK
Have any thoughts about
Photocure ASA?
Write Note

Gross Margin
Photocure ASA

94.5%
Current
94%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.5%
=
Gross Profit
485.4m
/
Revenue
513.6m

Gross Margin Across Competitors

Country NO
Market Cap 1.3B NOK
Gross Margin
95%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 749.7B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.4T DKK
Gross Margin
85%
Country US
Market Cap 372B USD
Gross Margin
69%
Country US
Market Cap 257.3B USD
Gross Margin
77%
Country CH
Market Cap 200.4B CHF
Gross Margin
73%
Country UK
Market Cap 162.7B GBP
Gross Margin
82%
Country CH
Market Cap 179.9B CHF
Gross Margin
75%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Photocure ASA
Glance View

Market Cap
1.3B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
69.23 NOK
Undervaluation 30%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
94.5%
=
Gross Profit
485.4m
/
Revenue
513.6m
What is the Gross Margin of Photocure ASA?

Based on Photocure ASA's most recent financial statements, the company has Gross Margin of 94.5%.